Trends in prescribing <scp>anti‐obesity</scp> pharmacotherapy for paediatric weight management: Data from the <scp>POWER</scp> Work Group

Abstract

These data suggest the need for (a) additional robust paediatric drug trials to further develop the evidence base guiding use or non-use of pharmacotherapy in paediatric weight management, and (b) increased understanding of both facilitators and barriers to prescribing anti-obesity pharmacotherapy for youth with obesity.